Skip to content

Author

Shanmugarathinam Alagarsamy

We have 2 of 40 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Virus-based therapeutic platforms

The development of molecular virology, genetic engineering, and immunology has enabled the transformation of viruses into versatile platforms, including vaccine vectors, cancer therapeutics, gene delivery systems, and antimicrobial agents. Live-attenuated vaccines and inactivated vaccines are well-established strategie...

S. Muruganantham, Shanmugarathinam Alagarsamy, Dhanalakshmi Mohanaradj · 0 citations
Aug 2026

H3N2 Influenza: Clinical Insights, Antiviral Resistance, and Next-Generation Strategies for Global Control

H3N2 influenza needs a multi-pronged strategy to be effectively controlled through the integration of innovative vaccine technologies, innovative therapeutic strategies, and robust international collaboration to guarantee fair access and scalable interventions.

S. Muruganantham, Dhanalakshmi Mohanaradj, Shanmugarathinam Alagarsamy et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.